| 产品编号 | bs-46010P |
| 英文名称 | Recombinant SARS-Cov-2 Spike S1 protein (D614G), His & Avi (HEK293) |
| 中文名称 | 重组SARS冠状病毒2 Spike突变蛋白S1 (D614G)(His-Avi) |
| 别 名 | SARS-CoV-2 spike protein; 2019-nCOV Spike protein; Spike glycoprotein; Spike protein S1; Surface glycoprotein; Spike protein RBD; SPIKE_SARS2; 2019-nCOV Spike S1(D614G), Recombinant (His-Avi Tag); Recombinant SARS-Cov-2 Spike S1 protein (D614G), His & Avi (HEK293) 突变型新冠蛋白; 新冠病毒S蛋白突变体（D614G）; 重组新冠病毒 Spike突变蛋白RBD(D614G); 新型冠状病毒Spike突变体蛋白; |
| 理论分子量 | 77.9kDa |
| 检测分子量 | 110-130 kDa |
| 性 状 | Lyophilized or Liquid |
| 浓 度 | ＞0.5 mg/ml |
| 物 种 | SARS-Cov-2 |
| 序 列 | 14-683/1273 |
| 纯 度 | >95% as determined by SDS-PAGE |
| 纯化方法 | AC |
| 内毒素 | Not analyzed |
| 表达系统 | HEK293 cell |
| 活性 | Yes |
| 标签 | His & Avi |
| 缓 冲 液 | Lyophilized from 0.22 um filtered solution in PBS (pH=7.4). Normally 5% trehalose is added as protectant before lyophilization. |
| 保存条件 | Stored at -70℃ or -20℃. Avoid repeated freeze/thaw cycles. |
| 注意事项 | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| 产品介绍 |
The SARS-CoV-2 spike (S) protein is the target of vaccine design efforts to end the COVID-19 pandemic. Despite a low mutation rate, isolates with the D614G substitution in the S protein appeared early during the pandemic, and are now the dominant form worldwide. Here, we analyze the D614G mutation in the context of a soluble S ectodomain construct. SWISS: P0DTC2 Gene ID: 43740568 |
| 1、抗体溶解方法 | |
| 2、抗体修复方式 | |
| 3、常用试剂的配制 | |
| 4、免疫组化操作步骤 | |
| 5、免疫组化问题解答 | |
| 6、Western Blotting 操作步骤 | |
| 7、Western Blotting 问题解答 | |
| 8、关于肽链的设计 | |
| 9、多肽的溶解与保存 | |
| 10、酶标抗体效价测定程序 | |
